Co-Authors
This is a "connection" page, showing publications co-authored by Gerardo Botti and Gennaro Ciliberto.
Connection Strength
0.447
-
miR-579-3p controls melanoma progression and resistance to target therapy. Proc Natl Acad Sci U S A. 2016 08 23; 113(34):E5005-13.
Score: 0.170
-
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? J Exp Clin Cancer Res. 2020 Jun 11; 39(1):109.
Score: 0.055
-
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy). J Transl Med. 2018 07 21; 16(1):207.
Score: 0.049
-
Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting. Oncotarget. 2018 Jan 09; 9(3):3576-3589.
Score: 0.047
-
Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells. Cancer Lett. 2017 10 10; 406:93-104.
Score: 0.045
-
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas. Sci Rep. 2017 05 02; 7(1):1312.
Score: 0.045
-
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma. Cancer Immunol Immunother. 2014 Jul; 63(7):675-83.
Score: 0.036